Bora Pharmaceuticals Expands US Operations with $122.5M Acquisition
Bora Pharmaceuticals has acquired MacroGenics’ Maryland manufacturing operations for $122.5 million, expanding its U.S. footprint. This development offers new opportunities for AECM professionals in facility upgrades and compliance services.